Pharmacy Is Right For Me

JANUARY 3, 2024

“How can I make the biggest difference in the lives of others? How can I help the most people?” These questions often cross the minds of students as they navigate the labyrinth of career choices. Dr. Linda Gutierrez-Miller, one such student, embarked on a journey to answer these questions, ultimately choosing a career path that aligns with her goals of making a substantial impact and aiding a diverse range of individuals—clinical pharmacy.

Communication 306

Communication Insurance Patient Care 306

Drug Topics

JANUARY 3, 2024

The vaccine, called mRNA-1345, demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease with at least 2 signs or symptoms and 82.4% against the disease with at least 3 signs or symptoms.

Vaccines 209

Vaccines 209

Pharmacy Times

JANUARY 3, 2024

However, comprehensive policy and payment structures are needed to ensure care sustainability.

149

149

STAT

JANUARY 3, 2024

First, a light starts to flash. Then a high-pitched siren starts to blare. Then come the sounds of nearby doors being flung open, and the frantic footsteps of doctors and nurses rushing toward a restroom at the end of a hallway. They’re in a hurry for good reason. These distress signals have a specific meaning: Somebody in the bathroom is overdosing.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JANUARY 3, 2024

Liraglutide, a glucagon-like peptide 1 receptor agonist, has shown a clinically and significant reduction in glycated hemoglobin for those with type 2 diabetes.

149

149

STAT

JANUARY 3, 2024

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups. The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

144

144

STAT

JANUARY 3, 2024

Mapping the billions of cells that make up the brain is a task mammoth enough to keep hundreds of researchers across continents busy for years. But it’s just one of several ambitious projects the Allen Institute is helping tackle. The nonprofit research institute, based in Seattle, was founded in 2003 by Microsoft co-founder and philanthropist Paul Allen to go after big and basic scientific questions.

143

143

Pharmacy Times

JANUARY 3, 2024

Available data indicate that as much as 50% of all antibiotics prescribed for individuals may be either unnecessary or not administered in the most effective manner as recommended.

145

145

STAT

JANUARY 3, 2024

Margery Quackenbush was attending a board meeting of the nonprofit where she served as executive director when she felt a sharp, stabbing pain in her chest. As the organization’s president yelled at a board member, Quackenbush — then age 69 — noticed her heart tightening and felt terrified. After that day more than 15 years ago, her cardiologist began a series of tests.

142

142

Pharmacy Times

JANUARY 3, 2024

Investigators did not find any association between energy drink consumption during pregnancy and any adverse pregnancy outcomes.

144

144

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

JANUARY 3, 2024

As the J.P. | As the J.P. Morgan Healthcare Conference rolled on in San Francisco, BioNTech, Alnylam and many other companies updated investors on their strategies heading into 2024.

Vaccines 138

Vaccines 138

Pharmacy Times

JANUARY 3, 2024

Investigators found that those who used statins post-breast cancer diagnosis had a lower risk of breast cancer death when the median total cholesterol decreased.

132

132

Fierce Healthcare

JANUARY 3, 2024

A “pivotal year for price transparency” closed out with most—but not all—of the healthcare industry publishing their data publicly and at a higher quality, price transparency data startup Turquoise | A state-of-the-industry report released Thursday found steady improvements in the number of organizations releasing price data, as well as the comprehensiveness and usability of those data.

Hospitals 130

Hospitals 130

Fierce Pharma

JANUARY 3, 2024

Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk and Eli Lilly—overwhelming the market wi | Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk and Eli Lilly—overwhelming the market with their dominance.

128

128

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JANUARY 3, 2024

The survey reached more than 2,000 patients and found many patients frustrated by limited opportunities to communicate with their providers.

Communication 127

Communication 127

Fierce Pharma

JANUARY 3, 2024

As the J.P. Morgan Healthcare Conference moves into its third day, we're covering the latest developments here. | On Wednesday at the the J.P. Morgan Healthcare Conference, attendees will get a chance to hear from AbbVie, Amarin and several other pharmaceutical companies.

Pharmaceutical Companies 126

Pharmaceutical Companies Pharmaceutical Companies 126

pharmaphorum

JANUARY 3, 2024

The UK medicines regulator has launched its mutual recognition framework for authorising medicines in a move that it says will help to bring new drugs to patients in the UK more quickly.

124

124

Fierce Pharma

JANUARY 3, 2024

Gene therapies have been approved for certain patients with beta thalassemia. After a successful phase 3 readout, Agios hopes it can reach a unique subgroup and eventually all patients. | Gene therapies have been approved for certain patients with beta thalassemia. After a successful phase 3 readout, Agios hopes it can reach a unique subgroup and eventually all patients.

124

124

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JANUARY 3, 2024

Pharmacists involvement in HIV care and treatment has been shown to lead to clinically and statistically significant improvements in ART adherence, as well as greater viral load suppression for patients with HIV.

123

123

Fierce Pharma

JANUARY 3, 2024

As the J.P. Morgan Healthcare Conference kicked off in San Francisco, EY released its annual report on the industry's dealmaking firepower. | As the J.P. Morgan Healthcare Conference kicked off in San Francisco, EY released its annual report on the industry's dealmaking firepower. Plus, Moderna, bluebird and other companies updated investors on their businesses heading into 2024.

124

124

Fierce Healthcare

JANUARY 3, 2024

Hospitals and clinician groups are pushing back on federal regulators' proposal to enforce data blocking rules, arguing that the penalties are "excessive," "unfair" and will discourage participatio | Hospitals and medical groups are pushing back on federal regulators' proposal to enforce data blocking rules, arguing that the penalties are "excessive," "unfair" and will discourage participation in value-based care programs.

Hospitals 122

Hospitals 122

Pharmacy Times

JANUARY 3, 2024

Sleep duration is positively associated with quality of life in adolescents.

122

122

pharmaphorum

JANUARY 3, 2024

The race for obesity drug assets is becoming more intense as pharmaceutical companies strive to develop effective treatments for weight loss. This article explores the efficacy, potential sales, and market trends in the field of obesity drugs.

Pharmaceutical Companies 119

Pharmaceutical Companies Pharmaceutical Companies 119

STAT

JANUARY 3, 2024

I recently turned 25. I should be taking risks, jet-setting with other Barbies, and flouncing around in tiny tops. Instead, this chronically ill Barbie spent her first four days of 25 in a scene from “Oppenheimer.” On my birthday, I spent nine hours convening with specialists three hours away from home. I contemplated my mortality as we decided which of my overlapping chronic health conditions is the worst so we can make the most of the final year I’m on my parents’ h

Insurance 118

Insurance 118

Pharmaceutical Technology

JANUARY 3, 2024

A new report from Novotech delves into the multifaceted landscape of HIV, focusing on its impact, treatment, and global initiatives.

118

118

STAT

JANUARY 3, 2024

Hospitals and clinics are expecting a slightly better 2024 compared to last year thanks to a return to mostly in-person care, patients resuming preventive visits and the gradual easing of labor costs and shortages. Still, the evaporation of pandemic-related emergency funding will deal a blow to resource-strained health systems, and leaders say they’ll ramp up tech investments, including in artificial intelligence-based tools.

Hospitals 115

Hospitals Insurance 115

Fierce Pharma

JANUARY 3, 2024

When GSK laid out $90 million upfront to acquire rights to Scynexis’ antifungal Brexafemme last spring, the British pharma threw a lifeline to a company whose blockbuster launch ambitions had hit t | GSK has downgraded a licensing deal for Scynexis' antifungal ibrexafungerp following an ongoing recall of the drug's approved form, Brexafemme.

113

113

Drug Topics

JANUARY 3, 2024

Although the study identified an increase in chronic symptoms among children that developed post-COVID-19 condition, the chance of initial development was low.

112

112

Drug Store News

JANUARY 3, 2024

Since joining the 100-store employee-owned pharmacy chain in 2007, Heiser has held several roles with the company with a focus on strategy, technology, business development and strategic partnerships.

111

111

Fierce Healthcare

JANUARY 3, 2024

Blue Shield of California has reduced its staff by 140 employees, a spokesperson confirmed to Fierce Healthcare. | Blue Shield of California is the most recent payer to announce layoffs, with a spokesperson confirming 140 people will lose their jobs.

106

106

European Pharmaceutical Review

JANUARY 3, 2024

Korserdu ® (elacestrant) is the first treatment indicated for ER+, HER2- advanced or metastatic breast cancer tumours with ESR1 mutations. The endocrine therapy has been granted a marketing authorisation by the UK Medicines & Healthcare products Regulatory Agency (MHRA). This represents the first endocrine therapy innovation in nearly 20 years. The small molecule treatment is authorised for postmenopausal women, and men, with oestrogen receptor (ER)-positive, HER2-negative, locally advanced

105

105

pharmaphorum

JANUARY 3, 2024

UK report calls for the mothballed Rosalind Franklin Lab to be repurposed as a manufacturing unit to support clinical trials of bacteriophages as new antimicrobial agents

105

105

The Checkup by Singlecare

JANUARY 3, 2024

Ozempic (semaglutide) is touted as a “miracle drug” for its ability to lower blood sugar for people with Type 2 diabetes and off-label to help people with obesity reach a healthy weight. It’s in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists that “work on a type of receptor in our small intestines,” explains Dawn Mancuso, MD , a primary care physician and medical weight loss specialist at Madison Wellness & Aesthetics Center in Madison, Alabama.

Documentation 105

Documentation Compounding Dosage Labelling 105